Iron-binding drugs targeted to lysosomes: a potential strategy to treat inflammatory lung disorders

Author： Persson H Lennart   Richardson Des R  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.8, 2005-08, pp. : 997-1008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA

By Taratula Oleh   Garbuzenko Olga B.   Chen Alex M.   Minko Tamara  

Journal of Drug Targeting, Vol. 19, Iss. 10, 2011-12 ,pp. : 900-914

Informa Healthcare

Access to resources Recommend Favorite

IL-22 inhibitors to treat inflammatory disorders such as arthritis

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 373-375

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotection and Drugs Used to Treat Psychiatric Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 12, Iss. 4, 2007-08 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 35-37

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drugs for Inflammatory Lung Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 39-52

Bentham Science Publishers

Access to resources Recommend Favorite